[{"Assets_0_Q2_USD":7033471000.0,"CommonStockSharesOutstanding_0_Q2_shares":256671000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":788533000.0,"NetIncomeLoss_2_Q2_USD":536058000.0,"NetIncomeLoss_1_Q2_USD":267427000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":255941000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":256154000.0,"EarningsPerShareBasic_1_Q2_USD":1.04,"EarningsPerShareBasic_2_Q2_USD":2.09,"Ticker":"VRTX","CIK":"875320","name":"VERTEX PHARMACEUTICALS INC \/ MA","OfficialName":"Vertex Pharmaceuticals Incorporated Common Stock","form":"10-Q","period":"20190630","fy":"2019.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"72193451271.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"SP500","filed":"20190801"}]